GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inovio Pharmaceuticals Inc (MEX:INO) » Definitions » Cyclically Adjusted PB Ratio

Inovio Pharmaceuticals (MEX:INO) Cyclically Adjusted PB Ratio : 0.44 (As of Jun. 24, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Inovio Pharmaceuticals Cyclically Adjusted PB Ratio?

As of today (2024-06-24), Inovio Pharmaceuticals's current share price is MXN148.00. Inovio Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was MXN337.03. Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 0.44.

The historical rank and industry rank for Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:

MEX:INO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.19   Med: 3.05   Max: 18.5
Current: 0.37

During the past years, Inovio Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 18.50. The lowest was 0.19. And the median was 3.05.

MEX:INO's Cyclically Adjusted PB Ratio is ranked better than
77.13% of 656 companies
in the Biotechnology industry
Industry Median: 1.615 vs MEX:INO: 0.37

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Inovio Pharmaceuticals's adjusted book value per share data for the three months ended in Mar. 2024 was MXN67.064. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN337.03 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Inovio Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inovio Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Inovio Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.00 5.52 2.85 0.84 0.28

Inovio Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.24 0.21 0.28 0.64

Competitive Comparison of Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Inovio Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=148.00/337.03
=0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inovio Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Inovio Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=67.064/131.7762*131.7762
=67.064

Current CPI (Mar. 2024) = 131.7762.

Inovio Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201406 314.366 100.560 411.955
201409 311.100 100.428 408.209
201412 324.116 99.070 431.118
201503 310.568 99.621 410.811
201506 473.424 100.684 619.623
201509 542.584 100.392 712.208
201512 501.970 99.792 662.853
201603 488.698 100.470 640.973
201606 489.230 101.688 633.986
201609 460.754 101.861 596.071
201612 411.822 101.863 532.760
201703 320.479 102.862 410.564
201706 344.877 103.349 439.739
201709 390.772 104.136 494.494
201712 371.395 104.011 470.537
201803 271.593 105.290 339.915
201806 287.146 106.317 355.908
201809 246.177 106.507 304.584
201812 210.683 105.998 261.920
201903 185.179 107.251 227.525
201906 125.366 108.070 152.867
201909 80.591 108.329 98.034
201912 7.670 108.420 9.322
202003 355.444 108.902 430.105
202006 324.978 108.767 393.725
202009 512.536 109.815 615.035
202012 589.109 109.897 706.395
202103 681.510 111.754 803.609
202106 578.070 114.631 664.529
202109 532.016 115.734 605.759
202112 452.593 117.630 507.024
202203 374.557 121.301 406.903
202206 290.348 125.017 306.047
202209 258.033 125.227 271.529
202212 205.548 125.222 216.307
202303 164.003 127.348 169.706
202306 129.981 128.729 133.058
202309 107.066 129.860 108.646
202312 87.391 129.419 88.982
202403 67.064 131.776 67.064

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Inovio Pharmaceuticals  (MEX:INO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Inovio Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Inovio Pharmaceuticals (MEX:INO) Business Description

Traded in Other Exchanges
Address
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.